StockData
Concentra Group Holdings Parent, Inc. logo

Concentra Group Holdings Parent, Inc. (CON) company profile

CONNYSEServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3019% above fair value
$42.99−0.46 (-1.06%)

Close on Nov 12, 2026Market cap $5.48BP/E 25.6Yield 0.58%

About Concentra Group Holdings Parent

Services-Specialty Outpatient Facilities, NEC, SIC 8093

Concentra provides occupational health services, employer health services, and direct-to-employer healthcare across the United States. Its core operations encompass three segments: occupational health centers, onsite health clinics, and other complementary businesses. The company delivers injury care and treatment for workers' compensation, physical therapy, and consumer health services. Its employer-focused solutions include pre-placement physical examinations, Department of Transportation certifications, substance abuse screenings, vaccinations, and workplace safety consultative services. The company also operates telemedicine platforms, affiliated pharmacy dispensing, and medical compliance programs. Concentra primarily serves employers across diverse industries, ranging from small businesses to Fortune 100 enterprises.

As of December 31, 2025, the company operated 628 stand-alone occupational health centers across 41 states and 411 onsite health clinics at employer worksites in 44 states. Overall, its healthcare delivery network extends across 47 states and the District of Columbia, supported by roughly 13,000 colleagues and affiliated clinicians who treat an average of 53,000 patients each business day. The provided text does not state the company's headquarters location.

Summary of the business section of Concentra Group Holdings Parent's latest annual report, written by StockData.

Company profile

Company

Legal name
Concentra Group Holdings Parent, Inc.
Founded
1979
Headquarters
Addison, TX
Address
5080 Spectrum Drive, Suite 1200w 75001
Phone
(972) 364-8000
Employees
13,133, Dec 31, 2025
Industry
Services-Specialty Outpatient Facilities, NEC
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Dallas, Texas

Stock & identifiers

Ticker
CON
Exchange
NYSE
IPO date
Jul 26, 2024
Shares outstanding
128M, Jul 31, 2026
Public float
$2.37B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
2014596
CUSIP
20603L102
ISIN
US20603L1026
FIGI
BBG01NBZ7QD9
Share class FIGI
BBG01NBZ7R83
EIN
30-1006613

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Matthew T. DiCanioSee Remarks, Director471,770
Raymond Tanner NewtonEVP & Chief Financial Officer114,098
Timothy F. RyanSee Remarks148,834
Jonathan P. ConserSee Remarks155,482
Michael D. RhineSee Remarks112,176
Danielle KendallSee Remarks101,440
Giovanni GallaraSee Remarks153,502
John Robert Anderson Jr.See Remarks100,380
John A. deLorimierSee Remarks147,559
Michael A. KosuthSee Remarks153,656
Greg M. GilbertSee Remarks148,834
Thomas A. DevasiaSee Remarks143,514
Douglas R. McAndrewSee Remarks155,482
Su Zan NelsonSee Remarks102,291
Robert A. OrtenzioDirector5,852,211
William Keith NewtonDirector577,375
Daniel ThomasDirector77,989
Marc R. WatkinsDirector24,729
Cheryl PegusDirector24,729
Brigid A. BonnerDirector19,485
Vipin GopalDirector19,485

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$7.40M$7.39M$3.05M$89$110
FY2024$7.08M$6.33M$3.53M$88$93

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
William K. Newton
Chief Executive Officer (Principal Executive Officer)
$843.08K$4.36M$2.13M$75.44K$7.40M+5%
Matthew T. DiCanio
President and Chief Financial Officer (Principal Financial Officer)
$573.85K$3.48M$1.15M$59.23K$5.27M-20%
John A. deLorimier
Executive Vice President, Chief Information and Technology Officer
$450.00K$1.16M$675.00K$28.28K$2.31M-18%
Timothy Ryan
Executive Vice President and Chief Legal Counsel
$450.00K$1.16M$675.00K$25.99K$2.31M–
John Anderson
Executive Vice President, Chief Medical Officer
$450.00K$1.16M$675.00K$25.76K$2.31M-18%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Jul 26, 2024
Offer price
$23.50
Securities offered
22,500,000
Gross proceeds
$528.75M
Exchange
NYSE
First trading day
Jul 25, 2024
First-day close
$22.48-4.3%
Lock-up ends (est.)
Jan 21, 2025

“The initial public offering price is $23.50 per share of our common stock.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 13,133 colleagues and affiliated physicians and clinicians who support the delivery of an extensive suite of services, including 9,967 full-time and 32 part-time, and 3,134 per-diem employees.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?